Intrahepatic Cholangiocarcinoma: expert consensus statement

Dodson, 2013, Intrahepatic cholangiocarcinoma: management options and emerging therapies, J Am Coll Surg, 217, 736, 10.1016/j.jamcollsurg.2013.05.021 Maithel, 2013, Multidisciplinary approaches to intrahepatic cholangiocarcinoma, Cancer, 119, 3929, 10.1002/cncr.28312 Luo, 2014, Survival outcomes and prognostic factors of surgical therapy for all potentially resectable intrahepatic cholangiocarcinoma: a large single-center cohort study, J Gastrointest Surg, 18, 562, 10.1007/s11605-013-2447-3 Gleeson, 2008, EUS-guided FNA of regional lymph nodes in patients with unresectable hilar cholangiocarcinoma, Gastrointest Endosc, 67, 438, 10.1016/j.gie.2007.07.018 Levy, 2012, Endoscopic ultrasound staging of cholangiocarcinoma, Curr Opin Gastroenterol, 28, 244, 10.1097/MOG.0b013e32835005bc Xu, 2012, Contrast-enhanced ultrasound of intrahepatic cholangiocarcinoma: correlation with pathological examination, Br J Radiol, 1016, 1029, 10.1259/bjr/21653786 Valls, 2000, Intrahepatic peripheral cholangiocarcinoma: CT evaluation, Abdom Imaging, 25, 490, 10.1007/s002610000079 Hamrick-Turner, 1992, Intrahepatic cholangiocarcinoma: MR appearance, AJR Am J Roentgenol, 158, 77, 10.2214/ajr.158.1.1309221 Murakami, 1995, Contrast-enhanced MR imaging of intrahepatic cholangiocarcinoma: pathologic correlation study, J Magn Reson Imaging, 5, 165, 10.1002/jmri.1880050210 Kim, 2003, Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma, Eur J Nucl Med Mol Imaging, 30, 1467, 10.1007/s00259-003-1297-8 Chong, 2012, Differentiating mass-forming intrahepatic cholangiocarcinoma from atypical hepatocellular carcinoma using gadoxetic acid-enhanced MRI, Clin Radiol, 67, 766, 10.1016/j.crad.2012.01.004 Corvera, 2008, 18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer, J Am Coll Surg, 206, 57, 10.1016/j.jamcollsurg.2007.07.002 Edge, 2009 Farges, 2011, AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: by the AFC-IHCC-2009 study group, Cancer, 117, 2170, 10.1002/cncr.25712 Nathan, 2009, A proposed staging system for intrahepatic cholangiocarcinoma, Ann Surg Oncol, 16, 14, 10.1245/s10434-008-0180-z Hyder, 2014, A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an East and West experience, JAMA Surg, 149, 432, 10.1001/jamasurg.2013.5168 Ribero, 2012, Surgical approach for long-term survival of patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis of 434 patients, Arch Surg, 147, 1107, 10.1001/archsurg.2012.1962 Endo, 2008, Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection, Ann Surg, 248, 84, 10.1097/SLA.0b013e318176c4d3 Hyder, 2013, Recurrence after operative management of intrahepatic cholangiocarcinoma, Surgery, 153, 811, 10.1016/j.surg.2012.12.005 Sulpice, 2012, Treatment of recurrent intrahepatic cholangiocarcinoma, Br J Surg, 99, 1711, 10.1002/bjs.8953 Farges, 2011, Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study group, Ann Surg, 254, 824, 10.1097/SLA.0b013e318236c21d El Rassi, 1999, Peripheral cholangiocarcinoma: presentation, diagnosis, pathology and management, Eur J Surg Oncol, 25, 375, 10.1053/ejso.1999.0660 Lang, 2009, Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients, J Am Coll Surg, 208, 218, 10.1016/j.jamcollsurg.2008.10.017 Ali, 2013, Role of major vascular resection in patients with intrahepatic cholangiocarcinoma, Ann Surg Oncol, 20, 2023, 10.1245/s10434-012-2808-2 de Jong, 2011, Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment, J Clin Oncol, 29, 3140, 10.1200/JCO.2011.35.6519 Jonas, 2009, Extended liver resection for intrahepatic cholangiocarcinoma: a comparison of the prognostic accuracy of the fifth and sixth editions of the TNM classification, Ann Surg, 249, 303, 10.1097/SLA.0b013e318195e164 Ercolani, 2010, Intrahepatic cholangiocarcinoma: primary liver resection and aggressive multimodal treatment of recurrence significantly prolong survival, Ann Surg, 252, 107, 10.1097/SLA.0b013e3181e462e6 Ohtsuka, 2009, Significance of repeated resection for recurrent intrahepatic cholangiocarcinoma, Hepatogastroenterology, 56, 1 Nakagawa, 2005, Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma, World J Surg, 29, 728, 10.1007/s00268-005-7761-9 Weber, 2001, Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes, J Am Coll Surg, 193, 384, 10.1016/S1072-7515(01)01016-X Shimada, 2009, Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement, Surgery, 145, 411, 10.1016/j.surg.2008.11.010 Choi, 2009, The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival, Ann Surg Oncol, 16, 3048, 10.1245/s10434-009-0631-1 Okami, 2003, Patterns of regional lymph node involvement in intrahepatic cholangiocarcinoma of the left lobe, J Gastrointest Surg, 7, 850, 10.1007/s11605-003-0029-5 Aoba, 2013, Assessment of nodal status for perihilar cholangiocarcinoma: location, number, or ratio of involved nodes, Ann Surg, 257, 718, 10.1097/SLA.0b013e3182822277 Tamandl, 2008, Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma, Ann Surg Oncol, 15, 2787, 10.1245/s10434-008-0081-1 Goere, 2006, Utility of staging laparoscopy in subsets of biliary cancers: laparoscopy is a powerful diagnostic tool in patients with intrahepatic and gallbladder carcinoma, Surg Endosc, 20, 721, 10.1007/s00464-005-0583-x D'Angelica, 2003, The role of staging laparoscopy in hepatobiliary malignancy: prospective analysis of 401 cases, Ann Surg Oncol, 10, 183, 10.1245/ASO.2003.03.091 Allen, 1949, Combined liver cell and bile duct carcinoma, Am J Pathol, 25, 647 Goodman, 1985, Combined hepatocellular–cholangiocarcinoma. A histologic and immunohistochemical study, Cancer, 55, 124, 10.1002/1097-0142(19850101)55:1<124::AID-CNCR2820550120>3.0.CO;2-Z Yano, 2003, Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases, Jpn J Clin Oncol, 33, 283, 10.1093/jjco/hyg056 Yin, 2012, Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis, Ann Surg Oncol, 19, 2869, 10.1245/s10434-012-2328-0 1989, The general rules for the clinical and pathological study of primary liver cancer. Liver Cancer Study Group of Japan, Jpn J Surg, 19, 98, 10.1007/BF02471576 Koh, 2005, Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma, Am J Surg, 189, 120, 10.1016/j.amjsurg.2004.03.018 Kim, 2009, Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma, Ann Surg Oncol, 16, 623, 10.1245/s10434-008-0278-3 Jarnagin, 2002, Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors, Cancer, 94, 2040, 10.1002/cncr.10392 Wang, 2010, Outcome of combined hepatocellular and cholangiocarcinoma of the liver, J Oncol, 2010, 10.1155/2010/917356 Lee, 2011, Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma, J Clin Gastroenterol, 45, 69, 10.1097/MCG.0b013e3181ce5dfa Theise, 2010, Combined hepatocellular-cholangiocarcinoma, 225 Fowler, 2013, Combined hepatocellular and cholangiocarcinoma (biphenotypic) tumors: imaging features and diagnostic accuracy of contrast-enhanced CT and MRI, AJR Am J Roentgenol, 201, 332, 10.2214/AJR.12.9488 Portolani, 2008, Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience, Ann Surg Oncol, 15, 1880, 10.1245/s10434-008-9933-y Groeschl, 2013, Transplantation versus resection for patients with combined hepatocellular carcinoma-cholangiocarcinoma, J Surg Oncol, 107, 608, 10.1002/jso.23289 El-Serag, 2009, Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population-based study of US veterans, Hepatology, 49, 116, 10.1002/hep.22606 Hammill, 2008, Intrahepatic cholangiocarcinoma: a malignancy of increasing importance, J Am Coll Surg, 207, 594, 10.1016/j.jamcollsurg.2008.04.031 Nathan, 2007, Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysis, J Gastrointest Surg, 11, 1488, 10.1007/s11605-007-0282-0 Jarnagin, 2003, Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies, Cancer, 98, 1689, 10.1002/cncr.11699 Hasegawa, 2007, Surgical resection of hilar cholangiocarcinoma: analysis of survival and postoperative complications, World J Surg, 31, 1256, 10.1007/s00268-007-9001-y Yamamoto, 2001, Recurrence after surgical resection of intrahepatic cholangiocarcinoma, J Hepatobiliary Pancreat Surg, 8, 154, 10.1007/s005340170039 Macdonald, 2002, Palliative and postoperative radiotherapy in biliary tract cancer, Surg Oncol Clin N Am, 11, 941, 10.1016/S1055-3207(02)00038-8 Todoroki, 2000, Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma, Int J Radiat Oncol Biol Phys, 46, 581, 10.1016/S0360-3016(99)00472-1 Pitt, 1995, Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival, Ann Surg, 221, 788, 10.1097/00000658-199506000-00017 Takada, 2002, Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma, Cancer, 95, 1685, 10.1002/cncr.10831 Neoptolemos, 2012, Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial, JAMA, 308, 147, 10.1001/jama.2012.7352 Horgan, 2012, Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis, J Clin Oncol, 30, 1934, 10.1200/JCO.2011.40.5381 Eckel, 2007, Emerging drugs for biliary cancer, Expert Opin Emerg Drugs, 12, 571, 10.1517/14728214.12.4.571 Valle, 2010, Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer, N Engl J Med, 362, 1273, 10.1056/NEJMoa0908721 Hezel, 2008, Systemic therapy for biliary tract cancers, Oncologist, 13, 415, 10.1634/theoncologist.2007-0252 Hezel, 2010, Genetics of biliary tract cancers and emerging targeted therapies, J Clin Oncol, 28, 3531, 10.1200/JCO.2009.27.4787 Jarnagin, 2006, Differential cell cycle-regulatory protein expression in biliary tract adenocarcinoma: correlation with anatomic site, pathologic variables, and clinical outcome, J Clin Oncol, 24, 1152, 10.1200/JCO.2005.04.6631 Thomas, 2007, Biological characteristics of cancers in the gallbladder and biliary tract and targeted therapy, Crit Rev Oncol Hematol, 61, 44, 10.1016/j.critrevonc.2006.07.006 Subbiah, 2013, Targeted therapy of advanced gallbladder cancer and cholangiocarcinoma with aggressive biology: eliciting early response signals from phase 1 trials, Oncotarget, 4, 153, 10.18632/oncotarget.832 Lee, 2012, Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary tract cancer: a multicentre, open-label, randomised, phase 3 study, Lancet Oncol, 13, 181, 10.1016/S1470-2045(11)70301-1 Kiefer, 2011, Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol: a 2-center study, Cancer, 117, 1498, 10.1002/cncr.25625 Park, 2011, Transarterial chemoembolization versus supportive therapy in the palliative treatment of unresectable intrahepatic cholangiocarcinoma, Clin Radiol, 66, 322, 10.1016/j.crad.2010.11.002 Vogl, 2012, Transarterial chemoembolization in the treatment of patients with unresectable cholangiocarcinoma: results and prognostic factors governing treatment success, Int J Cancer, 131, 733, 10.1002/ijc.26407 Shen, 2011, Adjuvant transcatheter arterial chemoembolization for intrahepatic cholangiocarcinoma after curative surgery: retrospective control study, World J Surg, 35, 2083, 10.1007/s00268-011-1171-y Kuhlmann, 2012, Treatment of unresectable cholangiocarcinoma: conventional transarterial chemoembolization compared with drug eluting bead–transarterial chemoembolization and systemic chemotherapy, Eur J Gastro Hepatol, 24, 437 Hoffmann, 2012, Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival, Cardiovasc Intervent Radiol, 35, 105, 10.1007/s00270-011-0142-x Saxena, 2010, Yttrium-90 radiotherapy for unresectable intrahepatic cholangiocarcinoma: a preliminary assessment of this novel treatment option, Ann Surg Oncol, 17, 484, 10.1245/s10434-009-0777-x Ibrahim, 2008, Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study, Cancer, 113, 2119, 10.1002/cncr.23818 Jarnagin, 2009, Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival, Ann Oncol, 20, 1589, 10.1093/annonc/mdp029